ARDX Ardelyx Inc

Ardelyx Inc is a clinical stage biopharmaceutical company. It engages in the discovery, development and commercialization of non-systemic, molecule therapeutics that work in the gastrointestinal tract to treat cardio-renal and metabolic diseases.

$1.38  -0.14 (-9.21%)
As of 12/06/2021 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/19/2014
Outstanding shares:  112,743,408
Average volume:  34,892,681
Market cap:   $171,369,980
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    039697107
ISIN:        US0396971071
Sedol:      BN89V40
Valuation   (See tab for details)
PE ratio:   -1.03
PB ratio:   1.81
PS ratio:   15.76
Return on equity:   -185.19%
Net income %:   -1,386.48%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy